Glyphosate cancer warning rejected: US appeals court rebuffs California’s attempt to require label that conflicts with global consensus that the herbicide is safe as used

screen sh jpg

A U.S. appeals court recently ruled that California lacks the authority to enforce a regulation mandating cancer warnings on glyphosate, the main active compound in Monsanto’s widely used herbicide Roundup, which was acquired by Bayer in 2018. The Ninth Circuit ruled Nov. 7 that the most recent warning issued by the state of California perpetuates the assertion that the chemical is hazardous, a claim deemed “at best disputed,” Law360 reported.

The Ninth Circuit’s split panel upheld a summary judgment by a California federal judge, affirming the invalidity of the state’s updated glyphosate safe harbor warning. The published opinion emphasized that the most recent warning would compel companies to communicate a “controversial, fiercely contested message that they fundamentally disagree with,” rendering it unsustainable.

Follow the latest news and policy debates on sustainable agriculture, biomedicine, and other ‘disruptive’ innovations. Subscribe to our newsletter.

The panel underscored the absence of a scientific consensus regarding glyphosate’s carcinogenic properties, noting that although the International Agency for Research on Cancer (IARC) identified it as a probable human carcinogen in 2015, this viewpoint is not universally accepted within the scientific community.

Consequently, the proposed warning stating that “glyphosate is known to cause cancer” was deemed contentious and not purely factual, as the term “known” carries legal nuance not readily apparent to consumers without context.

In light of the lack of unanimity on the chemical’s impact, the panel asserted that California can only mandate commercial speech if it satisfies the requirements of intermediate scrutiny. The court concluded that none of the proposed glyphosate Proposition 65 warnings met these criteria, rendering the application of the warning unconstitutional.

This is an excerpt. Read the original post here

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.noReviewsLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Jul-22-2026-09_13_07-AM
Viewpoint—The Strategic Litigation boom: Understanding the tightening coalition among NGOs, foundations, journalists, and tort lawyers
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
diversity
We are entering a new era of personalized medicine—if you’re white
How to Include More Strawberries in Your Diet
Strawberries are berries—and 35 other surprising food and drink myths
close up arabica coffee farmer s hands picking beans plant his farm colombia
Viewpoint: Why do so many ‘mainstream’ and ‘respected’ media outlets exaggerate climate change threats?
Screenshot-2026-07-07-at-12.55.44-PM
Viewpoint: Yes, we can adapt to a changing climate without devastating the environment and the economy
ChatGPT-Image-May-22-2026-10_26_09-AM
Trump-RFK, Jr. National Science Board firings: Accountability vs. partisan meddling
ChatGPT-Image-Jun-25-2026-12_23_17-PM
No, Bill Gates did not secretly engineer ticks to promote veganism
organic scaled
Facts & Fallacies podcast: Organic food cuts pesticide exposure? A response to Dr. Rhonda Patrick
ChatGPT-Image-Jul-6-2026-02_25_26-PM
40 million Americans take glucosamine. If you have memory loss, it could accelerate cognitive decline.
kratom
Viewpoint: Kratom ‘supplement’ crisis: DEA sits on its hands while patient addictions to this ineffective drug  rise

Sorry. No data so far.

glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.